Sanofi India Profile
Key Indicators
- Authorised Capital ₹ 23.50 Cr
as on 30-07-2024
- Paid Up Capital ₹ 23.03 Cr
as on 30-07-2024
- Company Age 68 Year, 7 Months
- Last Filing with ROC 31 Dec 2023
- Open Charges ₹ 170.72 Cr
as on 30-07-2024
- Satisfied Charges ₹ 40.81 Cr
as on 30-07-2024
- Revenue 2.63%
(FY 2023)
- Profit -2.80%
(FY 2023)
- Ebitda 14.14%
(FY 2023)
- Net Worth -20.40%
(FY 2023)
- Total Assets -17.21%
(FY 2023)
About Sanofi India
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500674 and on the National Stock Exchange(NSE) under SANOFI.
The Corporate was formerly known as Hoechst Fedco Pharma Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 December 2023. It's a company limited by shares with an authorized capital of Rs 23.50 Cr and a paid-up capital of Rs 23.03 Cr.
The company currently has active open charges totaling ₹170.72 Cr. The company has closed loans amounting to ₹40.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sanofi India Limited India are Rachid Ayari as CFO and Radhika Shah as Company Secretary. Aditya Narayan, Usha Thorat, Rahul Bhatnagar, and Five other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Sanofi India Limited offer?
Sanofi India Limited offers a wide range of products and services, including Health Conditions, Bone, Joint & Muscle Care, Healthcare Devices, Diabetes Monitors, Popular Category, Bone & Joint Care, Pain Relief, Personal Care, Oral Care, Omega & Fish Oil.
Who are the key members and board of directors at Sanofi India?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rachid Ayari | CFO | 12-Jan-2024 | Current |
Rodolfo Hrosz  | Managing Director | 01-Jun-2022 | Current |
Radhika Shah  | Company Secretary | 01-Nov-2021 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vaibhav Karandikar | Director | 23-Feb-2021 | Current |
| Aditya Narayan | Director | 30-Apr-2016 | Current |
| Usha Thorat | Director | 30-Apr-2016 | Current |
| Rahul Bhatnagar | Director | 29-Jul-2020 | Current |
| Renee Amonkar | Whole-Time Director | 26-Sep-2023 | Current |
Eric Mansion  | Additional Director | 02-Jul-2024 | Current |
Financial Performance and Corporate Structure Insights of Sanofi India.
Sanofi India Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.63% increase. The company also saw a slight decrease in profitability, with a 2.8% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanofi India?
In 2023, Sanofi India had a promoter holding of 60.40% and a public holding of 39.59%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Limited Creation Date: 20 Sep 2001 | ₹19.75 Cr | Open |
Icici Limited Creation Date: 25 Oct 1993 | ₹5.00 Cr | Open |
State Bank Of India Creation Date: 31 Dec 1992 | ₹40.00 Cr | Open |
How Many Employees Work at Sanofi India?
Sanofi India has a workforce of 2191 employees as of Jul 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanofi India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanofi India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
